Diabetes Clinical Trials in North Carolina

Showing 321-340 of 612 trials

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

NCT02429258

Effect of Dapagliflozin on 24-hour Blood Glucose in Type 2 Diabetes Patients Inadequately Controlled With Either Metformin Or Insulin

Type II Diabetes

AstraZeneca226 participantsStarted May 2015

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Huntington Park, California, United States +23 more locations

COMPLETEDPhase 331 miles

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

NCT02298192

This trial is conducted in Europe, North America and the United States of America. The aim of this trial is to compare two different titration algorithms of insulin degludec/liraglutide.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S420 participantsStarted Nov 2014

Hamilton, Alabama, United States • Chandler, Arizona, United States • Glendale, Arizona, United States +81 more locations

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Diabetes Trials in Other Cities

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Risk Assessment of Long-Haul Truck Drivers

Active and Healthy Brotherhood: A Program for Chronic Disease Self-Management for Black Men

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Extended Follow-Up After Islet Transplantation in T1D

Healthy.io Method Comparison & User Performance Study

PK Study of Dapagliflozin in Pediatric Subjects With T2DM

A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients

A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes

A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin

Improving Outcomes in Underserved Women With GDM

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin

Other Conditions in North Carolina